Online inquiry

IVTScrip™ mRNA-Anti-MUC16, ACA125(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ1407MR)

This product GTTS-WQ1407MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets MUC16 gene. The antibody can be applied in Ovarian Cancer research.

Specifications
Product type	mRNA
Modified bases	N1-Methylpseudo-UTP
5' Cap	Cap 0
Species	Mus musculus
RefSeq	NM_024690.2
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	94025
UniProt ID	Q8WXI7

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-MUC16, ACA125(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WQ1407MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ1392MR	IVTScrip™ mRNA-Anti-IL1A&IL1B, ABT-981(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	ABT-981
GTTS-WQ13365MR	IVTScrip™ mRNA-Anti-LRRC15, PR-1498487(Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	PR-1498487
GTTS-WQ12928MR	IVTScrip™ mRNA-Anti-MUC1, PankoMab(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	PankoMab
GTTS-WQ14523MR	IVTScrip™ mRNA-Anti-IL6R, SA-237(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	SA-237
GTTS-WQ1779MR	IVTScrip™ mRNA-Anti-IL2RA, ADCT-301(unconjugated)(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	ADCT-301(unconjugated)
GTTS-WQ5017MR	IVTScrip™ mRNA-Anti-GP, c4G7-N(Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	c4G7-N
GTTS-WQ1966MR	IVTScrip™ mRNA-Anti-SLITRK6, AGS-15E(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	AGS-15E
GTTS-WQ833MR	IVTScrip™ mRNA-Anti-CD276, ABBV-155(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	ABBV-155

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST